Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin

Journal of Infection and Chemotherapy

Volumn 9, Issue 4, 2003, Pages 304-309

  Nakazawa, Hiroaki ^a   Kikuchi, Yuji ^a   Honda, Takashi ^a   Isago, Tsukasa ^a   Nozaki, Motohiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Combination therapy; FOM; MRSA

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFMETAZOLE; CEFOPERAZONE; CEFOTIAM; FLOMOXEF; FOSFOMYCIN; HABEKACIN; IMIPENEM; MINOCYCLINE; OFLOXACIN; PANIPENEM; SULBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BURN; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; STRAIN IDENTIFICATION;

EID: 0346732988     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0266-2     Document Type: Article

References (11)

1. Hendlin D, Stapley EO, Jackson M, Wallick H, Miller AK, Wolf FJ, et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science 1969;166:122-3.
2. Kouda M. In vitro effects of combinations of antibiotics against highly fosfomycin-resistant, methicillin-resistant Staphylococcus aureus: with special reference to efficacious combinations of imipenem/cilastatin and cephems. Jpn J Antibiot 1993;46:142-53.
3. Hayashi I, Sakurai M, Ichiki M, Sekine I, Nakayama K. Laboratory and clinical study on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa. Jpn J Antibiot 1994;47:29-39.
4. Hayashi I, Sakurai M, Karato A, Ichiki M, Sekine I, Ishikawa T. Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa. Jpn J Antibiot 1994;47:991-1005.
5. Niida M, Yoshida T. Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Jpn J Antibiot 1994;47:1-10.
6. Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, et al. A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological disease. Jpn J Antibiot 1995;48:514-21.
7. Shima K, Takenaka T, Takeshita Y, Ohtsubo S, Watanabe M, Tamiya J, et al. Clinical situation of MRSA infection in Kumamoto Prefecture and laboratory clinical evaluation (ETI method). Medical Consultation New Remedies 1991;28:69-80.
8. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Sraphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3.
9. Hayashi I, Hasegawa Y. Fosfomycin natorium, calcium. Jpn J Antibiot 1994;47:29-39.
10. Kahan FM, Kahan JS, Cassidy PJ, et al. The mechanism of action of fosfomycin. Ann N Y Acad Sci 1974;235:364-86.
11. Utsui Y, Ohya S, Magaribuchi T, Tajima M, Yokota T. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1986;30:917-22.